Bay Street News, 2020

Recruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN […]

ROLLING MEADOWS, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) — MYR Group Inc. (MYR Group) (NASDAQ: MYRG), a holding company of […]

Shenzhen, China, Sept. 14, 2020 (GLOBE NEWSWIRE) — ATIF Holdings Limited (Nasdaq: ATIF, the “Company”), a company providing business consulting […]

MALVERN, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing […]

– Caelum Biosciences, a company founded by Fortress, is collaborating with Alexion Pharmaceuticals on the studies– Phase 2 study met […]

BURLINGTON, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, announced today […]

BALA CYNWYD, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) — Global Indemnity Group, LLC (NASDAQ:GBLI) (the “Company”) announced today its Board […]

NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and […]

STOUGHTON, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being […]

SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed […]